Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) EPS (Basic): 2020-2023

Historic EPS (Basic) for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to -$1.88.

  • Immuneering's EPS (Basic) fell 4.00% to -$0.52 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.89, marking a year-over-year increase of 1.56%. This contributed to the annual value of -$1.88 for FY2023, which is 1.57% up from last year.
  • Immuneering's EPS (Basic) amounted to -$1.88 in FY2023, which was up 1.57% from -$1.91 recorded in FY2022.
  • In the past 5 years, Immuneering's EPS (Basic) ranged from a high of -$1.88 in FY2023 and a low of -$3.44 during FY2020.
  • For the 3-year period, Immuneering's EPS (Basic) averaged around -$2.08, with its median value being -$1.91 (2022).
  • Data for Immuneering's EPS (Basic) shows a peak YoY grew of 28.49% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Immuneering's EPS (Basic) stood at -$3.44 in 2020, then increased by 28.49% to -$2.46 in 2021, then grew by 22.36% to -$1.91 in 2022, then rose by 1.57% to -$1.88 in 2023.